Effects of ovary suppression by a long-acting GnRH-agonist on circulating GH, insulin-like growth factor I and insulin levels in women with polycystic ovary syndrome

Journal of Endocrinological Investigation

Volumn 20, Issue 4, 1997, Pages 220-224

  Tropeano, G ^a   Liberale, I ^a   Vuolo, I P ^a   Barini, A ^a   Caroli, G ^a   Carfagna, P ^a   Menini, E ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

GH IGF I axis; GnRH agonist treatment; Growth hormone; Insulin; PCOS

Indexed keywords

ANDROGEN; ESTROGEN; GLUCOSE; GONADORELIN AGONIST; GROWTH HORMONE; INSULIN; SEX HORMONE; SOMATOMEDIN C; TRIPTORELIN;

ADULT; ANDROGEN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN BLOOD LEVEL; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN RESPONSE; INTRAMUSCULAR DRUG ADMINISTRATION; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; STEROID BLOOD LEVEL;

EID: 0030872914     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346907     Document Type: Article

References (17)

1. Kazer R.R., Unterman T.G., Glick R.P. An abnormality of the growth hormone/insulin-like growth factor I axis in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 71: 958, 1990.
2. Acar B., Kadanali S. Diminished growth hormone responses to L-dopa in polycystic ovarian disease. Fertil Steril. 60: 984, 1993.
3. Lee E.J., Park K.H., Lee B.S., Song C.H., Lee H.C., Huh K.B. Growth hormone response to L-dopa and pyridostigmine in women with polycystic ovarian syndrome. Fertil Steril. 60: 53, 1993.
4. Piaditis G.P., Kounadi T.G., Rangou D.B., Trovas G.P., Kaklas N.A., Chlouverakis C.S. Dysfunction of the Growth Hormone/insulin-like growth factor-I axis in women with polycystic ovarian syndrome. Clin. Endocrinol. (Oxf.) 42: 635, 1995.
5. Yamashita S., Melmed S. Effects of insulin on rat anterior pituitary cells. Inhibition of growyh hormone secretion and mRNA levels. Diabetes 35: 440, 1986.
6. Insler V., Shohan Z., Barash A., Koistinen R., Seppala M., Hen M., Lunenfeld B., Zadik Z. Polycystic ovaries in nonobese and obese patients: possihte pathophysiological mechanism based on new interpretation of facts and findings. Hum Reprod. 8: 379, 1993.
7. Glass A.R. Endocrine aspects of obesity. Med. Clin. North Am. 73: 139, 1989.
8. Suikkari A.M., Koivisto V.A., Rutanen E.M., Yki-Jarvinen H., Karonen S.L., Seppala M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J. Clin. Endocrinol. Metab. 66: 266, 1988.
9. Berelowitz M., Szabo M., Frohman L.A. Firestone S., Chu L. Somatomedin-C mediates growth hormone negative feed-back by effects on both the hypothalamus and the pituitary. Science 212: 1279, 1981.
10. Namba H., Morita S., Melmed S. Insulin-like growth factor-I action on growth hormone secretion and messenger ribonucleic acid levels interaction with somatostatin. Endocrinology 124: 1794, 1989.
11. Adams J., Poison D.W., Franks S. Prevalence of polycystic ovaries in women with anovulation and hyrsutism. Br. Med. J. 293: 355, 1986.
12. Tropeano G., Lucisano A., Liberale, Barini A., Vuolo I.P., Martino G., Menini E., Dell'Acqua S. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 78: 305, 1994.
13. Urdl W. Polycystic ovarian disease: endocrinological parameters with specific reference to growth hormone and somatomedin-C. Arch. Gynecol. Obstel. 243: 13, 1988.
14. Daughaday W.H. Growth hormone, normal synthesis, secretion, control, and mechanism of action. In: DeGroot L.J. (Ed.), Sounders. Endocrinology Vol 1. Philadelphia, 1989, p. 318.
15. Shibasaki T., Masuda A., Hotta M., Yamauchi N., Hizuca N., Takanu K., Demura H., Shizume K. Effects of ingestion of glucose on GH and TSH secretion: evidence for stimulation of somatostatin release from the hypothalamus by acute hyperglycemia in normal man and its impairment in acromegalyc patients. Life SCi. 44: 431, 1989.
16. Peiris A.N., Mueller R.A., Struve M.F., Smith G.A., Kissebah A.H. Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women. J. Clin. Endocrinol. Metab. 64: 1627, 1987.
17. Urdl W., Desoye G., Schmon B., Hofmann H.M.N., Ralph G. Interactions between insulin and insulin-like growth factor I in the pathogenesis of polycystic ovarian disease. Ann. NY Acad. Sci. 626: 177, 1991.